Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer

G Wang, JJ Wang, Z Zhi-Min, XN Xu, F Shi… - Science …, 2023 - journals.sagepub.com
Colorectal cancer (CRC) can be resistant to platinum drugs, possibly through ferroptosis
suppression, albeit the need for further work to completely understand this mechanism. This …

[HTML][HTML] A randomized phase II study of Irinotecan plus cisplatin with or without simvastatin in ever-smokers with extended disease small cell lung cancer

Y Lee, SH Lee, GK Lee, EJ Lim… - Cancer Research and …, 2023 - synapse.koreamed.org
Purpose This study evaluated whether an addition of simvastatin to chemotherapy improves
survival in ever-smokers with extensive disease (ED)–small cell lung cancer (SCLC) …

Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells

Y Li, M Amrutkar, AV Finstadsveen, KT Dalen… - Cancer Cell …, 2023 - Springer
Background Despite therapeutic advances, the prognosis of pancreatic ductal
adenocarcinoma (PDAC) remains extremely poor. Metabolic reprogramming is increasingly …

[HTML][HTML] Immunologic aspects of dyslipidemia: a critical regulator of adaptive immunity and immune disorders

D Kim, H Chung, JE Lee, J Kim, J Hwang… - Journal of Lipid and …, 2021 - ncbi.nlm.nih.gov
Dyslipidemia is a major cause of cardiovascular diseases which represent a leading cause
of death in humans. Diverse immune cells are known to be involved in the pathogenesis of …

Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines

N Irie, K Mizoguchi, T Warita, M Nakano, K Sasaki… - Biomedicines, 2024 - mdpi.com
Metastatic melanoma has a very poor prognosis. Statins, 3-hydroxy-3-methyl-glutaryl-
coenzyme A reductase (HMGCR) inhibitors, are cholesterol-lowering agents with a potential …

The mevalonate pathway in breast cancer biology

A Göbel, RM Riffel, LC Hofbauer, TD Rachner - Cancer Letters, 2022 - Elsevier
Breast cancer affects one in eight women during their lifetime. Although diagnostic and
therapeutic options have improved, recurrence, metastasis, and therapeutic resistance …

Atorvastatin and Nitrofurantoin repurposed in the context of breast cancer and neuroblastoma cells

C Moura, AS Correia, M Pereira, E Ribeiro, J Santos… - Biomedicines, 2023 - mdpi.com
Chemotherapy still plays a central role in the treatment of cancer. However, it is often
accompanied by off-target effects that result in severe side-effects and development of drug …

A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of Mortality Following Pancreatic Cancer

K Anbari, MM Amiri… - Anti-Cancer Agents …, 2023 - ingentaconnect.com
Background: Pancreatic cancer (PC) is a type of cancer with a high incidence and case-
fatality rate. Objective: This study aimed to evaluate the role of statins in preventing mortality …

[HTML][HTML] Lipid metabolic reprogramming in embryonal neoplasms with MYCN amplification

J Talapatra, MM Reddy - Cancers, 2023 - mdpi.com
Tumor cells reprogram their metabolism, including glucose, glutamine, nucleotide, lipid, and
amino acids to meet their enhanced energy demands, redox balance, and requirement of …

Statins reduce hepatocellular carcinoma risk in patients with chronic kidney disease and end-stage renal disease: a 17-year longitudinal study

FC Sung, YT Yeh, CH Muo, CC Hsu, WC Tsai, YH Hsu - Cancers, 2022 - mdpi.com
Simple Summary Statins are medicines used to treat patients with high lipid levels
(hyperlipidemia). Studies have reported that patients undergoing statin therapy are at …